Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (RARE) Earnings Dates, Call Summary & Reports

1 Followers

Earnings Data

Estimated Report Date
Feb 18, 2027
TBA (Not Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
40.81
Last Year’s EPS
-24.03
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 20 Analysts Ratings

Ultragenyx Pharmaceutical (MX:RARE) Earnings, Revenues Date & History

-40.00-20.000.0020.0040.0060.00Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Q4 2026

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.

MX:RARE Q3 2026 Earnings Report

Earnings ReportEarnings Call SummaryEarnings AudioSlide Deck
MX:RARE Upcoming Earnings

Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

MX:RARE Earnings History

MX:RARE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress ReleaseSlidesPlay Transcript
Feb 18, 20272026 (Q4)40.81--24.03――――
Nov 03, 20262026 (Q3)-20.49-21.61-33.7135.91% (+12.11)―
Aug 04, 20262026 (Q2)-23.13-16.76-21.7923.08% (+5.03)―
May 05, 20262026 (Q1)-27.71-34.27-29.24-17.20% (-5.03)―
Feb 12, 20262025 (Q4)-20.36-24.03-25.897.19% (+1.86)―
Nov 04, 20252025 (Q3)-22.98-33.71-26.08-29.29% (-7.64)―
Aug 05, 20252025 (Q2)-24.16-21.79-28.3123.03% (+6.52)
May 06, 20252025 (Q1)-29.76-29.24-37.8122.66% (+8.57)
Feb 13, 20252024 (Q4)-24.36-25.89-28.318.55% (+2.42)
Nov 05, 20242024 (Q3)-27.64-26.08-41.5337.22% (+15.46)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.

Beat Missed

MX:RARE Earnings-Related Price Changes

MX:RARE earnings price reaction
Report DatePrice 1 Day BeforePrice 1 Day AfterPercentage Change
Nov 03, 2026Mex$256.00Mex$256.00+0.00%
Aug 04, 2026Mex$811.00Mex$811.00+0.00%
May 05, 2026Mex$811.00Mex$811.00+0.00%
Feb 12, 2026Mex$811.00Mex$811.00+0.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.

FAQ

When does Ultragenyx Pharmaceutical (MX:RARE) report earnings?
Ultragenyx Pharmaceutical (MX:RARE) is estimated to report earnings on Feb 18, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is MX:RARE EPS forecast?
MX:RARE EPS forecast for the fiscal quarter 2026 (Q4) is 40.81.